Cardiac Effects of BRAF and MEK Inhibitors: Mechanisms and Clinical Management

被引：0
|
作者：
Pierre-Yves Courand
Mathilde Berger
Anissa Bouali
Brahim Harbaoui
Pierre Lantelme
Stéphane Dalle
机构：
[1] Hôpital de La Croix-Rousse Et Hôpital Lyon Sud,Fédération de Cardiologie
[2] Hospices Civils de Lyon,Université de Lyon, CREATIS, CNRS UMR5220, INSERM U1044, INSA
[3] Université Claude Bernard Lyon 1,Lyon
[4] Hôpital de Lyon Sud,Service de Dermatologie
来源：
Current Oncology Reports | 2022年 / 24卷
关键词：
Melanoma; Cardiac toxicity; BRAF inhibitor; MEK inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：265 / 271
页数：6
相关论文
共 50 条
  • [11] CUTANEOUS GRANULOMATOUS REACTION AND OTHER CUTANEOUS EFFECTS OF BRAF AND MEK INHIBITORS
    Vallone, M. G.
    Gonzalez, V. M.
    Casas, J. G.
    Larralde, M.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2017, 56 (11) : 1231 - 1232
  • [12] Resistance to BRAF and MEK inhibitors in BRAF-mutant melanoma
    Patel, Hima
    Yacoub, Nour
    Garrett, Joan T.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB43 - AB43
  • [13] Allosteric MEK inhibitors act on BRAF/MEK complexes to block MEK activation
    Gonzalez-Del Pino, Gonzalo L.
    Li, Kunhua
    Park, Eunyoung
    Schmoker, Anna M.
    Ha, Byung Hak
    Eck, Michael J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (36)
  • [14] Undesirable cardiac Side Effects under BRAF and MEK Inhibitor Therapy
    Bossenecker, I.
    Seeber, O.
    Meiwes, A.
    Gonzalez, S. Sanchez
    Niessner, H.
    Sinnberg, T.
    Thomas, I.
    Forschner, A.
    Leiter-Stoppke, U.
    Garbe, C.
    Flatz, L.
    Eigentler, T.
    Amaral, T.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 90 - 90
  • [15] Combination of BRAF- and MEK- Inhibitors
    Voos, Dunja
    AKTUELLE DERMATOLOGIE, 2015, 41 (04) : 124 - 124
  • [16] Cutaneous Toxicities of BRAF and MEK Inhibitors in Children
    Loka, T.
    O'Hare, P.
    Mahon, C.
    Hargrave, D.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S133 - S133
  • [17] Subretinal fluid associated with MEK and BRAF inhibitors
    Attia, R.
    Comet, A.
    Stolowy, N.
    Fitoussi, R.
    Michel, T.
    Denis, D.
    David, T.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2022, 45 (09): : 1091 - 1092
  • [18] To Inhibit or Not to Inhibit MEK With BRAF Inhibitors: Is That the Question?
    Sullivan, Ryan J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (29) : 4613 - +
  • [19] BRAF and MEK inhibitors in therapy of advanced melanoma
    Kosela, Hanna
    Switaj, Tomasz
    Rutkowski, Piotr
    ONCOLOGY IN CLINICAL PRACTICE, 2011, 7 (05): : 246 - 253
  • [20] BRAF and MEK Inhibitors: Use and Resistance in BRAF-Mutated Cancers
    Sanchez, Jaquelyn N.
    Wang, Ton
    Cohen, Mark S.
    DRUGS, 2018, 78 (05) : 549 - 566
12345